Back to search
FDAFDA · Food and drugs·Recall number D-1035-2017

Amantadine HCl Capsules, USP, 100 mg, Rx Only, 50 Capsules (5x10) Unit Dose Cartons, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0069-15

Published August 9, 2017 · Recall initiated: June 19, 2017

Summary

FDA records drug Class II recall D-1035-2017, published August 9, 2017 and initiated June 19, 2017. Recalling firm: Apace KY LLC; Status: Terminated; Reported quantity: 1,483 cartons; Lot: Lot: 16710, exp 07/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apace KY LLC
Distributor
KY
Lot
Lot: 16710, exp 07/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amantadine HCl Capsules, USP, 100 mg, Rx Only, 50 Capsules (5x10) Unit Dose Cartons, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0069-15 recalled?

Yes. FDA published recall D-1035-2017 on August 9, 2017. Reported hazard: Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail